Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 89 results.
User Information
Export Records
  1. 1.   CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
  2. Majzner, Robbie G.; Theruvath, Johanna L.; Nellan, Anandani; Heitzeneder, Sabine; Cui, Yongzhi; Mount, Christopher W.; Rietberg, Skyler P.; Linde, Miles H.; Xu, Peng; Rota, Christopher; Sotillo, Elena; Labanieh, Louai; Lee, Daniel W.; Orentas, Rimas J.; Dimitrov, Dimiter S.; Zhu, Zhongyu; St Croix,Brad; Delaidelli, Alberto; Sekunova, Alla; Bonvini, Ezio; Mitra, Siddhartha S.; Quezado, Martha M.; Majeti, Ravindra; Monje, Michelle; Sorensen, Poul H. B.; Maris, John M.; Mackall, Crystal L.
  3. CLINICAL CANCER RESEARCH. 2019, APR 15; 25(8): 2560-2574.
  1. 2.   Transcription Factor Myeloid Zinc-Finger 1 Suppresses Human Gastric Carcinogenesis by Interacting with Metallothionein 2A
  2. Lin, Shuye; Wang, Xiaoyue; Pan, Yuanming; Tian, Rongmeng; Lin, Bonan; Jiang, Guosheng; Chen,Keqiang; He, Yuqi; Zhang, Lulu; Zhai, Wanli; Jin, Peng; Yang, Lang; Li, Guoqiang; Wu, Yun; Hu, Jiang; Gong, Wanghua; Chang, Zhijie; Sheng, Jian-qiu; Lu, Youyong; Wang,Jiming; Huang, Jiaqiang
  3. CLINICAL CANCER RESEARCH. 2019, Feb 1; 25(3): 1050-1062.
  1. 3.   Synthesis and Biological Activities of (R)- and (S)-N-(4-Methoxyphenyl)-N,2,6-trimethyl-6,7-dihydro-5H-cyclopenta[d]pyri midin-4-aminium Chloride as Potent Cytotoxic Antitubulin Agents
  2. Ganglee, A.; Zhao, Y.; Hamel, E.; Westbrook, C.; Mooberry, S. L.
  3. Journal of Medicinal Chemistry. 2011, Sep; 54(17): 6151-6155.
  1. 4.   Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1 alpha in Advanced Solid Tumors
  2. Kummar, S.; Raffeld, M.; Juwara, L.; Horneffer, Y.; Strassberger, A.; Allen, D.; Steinberg, S. M.; Rapisarda, A.; Spencer, S. D.; Figg, W. D.; Chen, X. H.; Turkbey, I. B.; Choyke, P.; Murgo, A. J.; Doroshow, J. H.; Melillo, G.
  3. Clinical Cancer Research. 2011, Aug; 17(15): 5123-5131.
  1. 5.   A set of aspartyl protease-deficient strains for improved expression of heterologous proteins in Kluyveromyces lactis
  2. Ganatra, M. B.; Vainauskas, S.; Hong, J. M.; Taylor, T. E.; Denson, J. P. M.; Esposito, D.; Read, J. D.; Schmeisser, H.; Zoon, K. C.; Hartley, J. L.; Taron, C. H.
  3. Fems Yeast Research. 2011, Mar; 11(2): 168-178.
  1. 6.   Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale
  2. Stumpel, D.; Schotte, D.; Lange-Turenhout, E. A. M.; Schneider, P.; Seslija, L.; de Menezes, R. X.; Marquez, V. E.; Pieters, R.; den Boer, M. L.; Stam, R. W.
  3. Leukemia. 2011, Mar; 25(3): 429-439.
  1. 7.   Down-Regulation of miR-101 in Endothelial Cells Promotes Blood Vessel Formation through Reduced Repression of EZH2
  2. Smits, M.; Mir, S. E.; Nilsson, R. J. A.; van der Stoop, P. M.; Niers, J. M.; Marquez, V. E.; Cloos, J.; Breakefield, X. O.; Krichevsky, A. M.; Noske, D. P.; Tannous, B. A.; Wurdinger, T.
  3. Plos One. 2011, Jan; 6(1): 11.
  1. 8.   Perturbation of the P-Body Component Mov10 Inhibits HIV-1 Infectivity
  2. Furtak, V.; Mulky, A.; Rawlings, S. A.; Kozhaya, L.; Lee, K.; KewalRamani, V. N.; Unutmaz, D.
  3. Plos One. 2010, Feb; 5(2): 10.
  1. 9.   Cdk2 plays a critical role in hepatocyte cell cycle progression and survival in the setting of cyclin D1 expression in vivo
  2. Hanse, E. A.; Nelsen, C. J.; Goggin, M. M.; Anttila, C. K.; Mullany, L. K.; Berthet, C.; Kaldis, P.; Crary, G. S.; Kuriyama, R.; Albrecht, J. H.
  3. Cell Cycle. 2009 8(17): 2802-2809.
  1. 10.   Cdk2 and Cdk4 Activities Are Dispensable for Tumorigenesis Caused by the Loss of p53
  2. Padmakumar, V. C.; Aleem, E.; Berthet, C.; Hilton, M. B.; Kaldis, P.
  3. Molecular and Cellular Biology. 2009 29(10): 2582-2593.
  1. 11.   Effects of Manganese Superoxide Dismutase Silencing on Androgen Receptor Function and Gene Regulation: Implications for Castration-Resistant Prostate Cancer
  2. Sharifi, N.; Hurt, E. M.; Thomas, S. B.; Farrar, W. L.
  3. Clinical Cancer Research. 2008 14(19): 6073-6080.
  1. 12.   Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines
  2. Hurt, E. M.; Thomas, S. B.; Peng, B.; Farrar, W. L.
  3. British Journal of Cancer. 2007, Oct; 97(8): 1116-1123.
  1. 13.   Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study
  2. Kang, D.; Lee, K. M.; Park, S. K.; Berndt, S. I.; Peters, U.; Reding, D.; Chatterjee, N.; Welch, R.; Chanock, S.; Huang, W. Y.; Hayes, R. B.
  3. Cancer Epidemiology Biomarkers & Prevention. 2007, Aug; 16(8): 1581-1586.
  1. 14.   Structural basis for viral late-domain binding to Alix
  2. Lee, S.; Joshi, A.; Nagashima, K.; Freed, E. O.; Hurley, J. H.
  3. Nature Structural & Molecular Biology. 2007, Mar; 14(3): 194-199.
  1. 15.   Reversal of p53 epigenetic silencing in multiple myeloma permits apoptosis by a p53 activator
  2. Hurt, E. M.; Thomas, S. B.; Peng, B.; Farrar, W. L.
  3. Cancer Biology & Therapy. 2006, Sep; 5(9): 1154-1160.
  1. 16.   Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors
  2. Khan, T.; Stauffer, J. K.; Williams, R.; Hixon, J. A.; Salcedo, R.; Lincoln, E.; Back, T. C.; Powell, D.; Lockett, S.; Arnold, A. C.; Sayers, T. J.; Wigginton, J. M.
  3. Journal of Immunology. 2006, MAY 15; 176(10): 6302-6312.
  1. 17.   Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure
  2. Liu, J.; Xie, Y. X.; Ducharme, D. M. K.; Shen, J.; Diwan, B. A.; Merrick, B. A.; Grissom, S. F.; Tucker, C. J.; Paules, R. S.; Tennant, R.; Waalkes, M. P.
  3. Environmental Health Perspectives. 2006, MAR; 114(3): 404-411.
  1. 18.   Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy
  2. Boguslavsky, R. L.; Stewart, C. L.; Worman, H. J.
  3. Human Molecular Genetics. 2006, FEB 15; 15(4): 653-663.
  1. 19.   Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR
  2. Boyd, K. E.; Xiao, Y. Y.; Fan, K.; Poholek, A.; Copeland, N. G.; Jenkins, N. A.; Perkins, A. S.
  3. Blood. 2006, JAN 15; 107(2): 733-741.
  1. 20.   Role of GADD34 in modulation of cisplatin cytotoxicity
  2. Fishel, M. L.; Rabik, C. A.; Bleibel, W. K.; Li, X. M.; Moschel, R. C.; Dolan, M. E.
  3. Biochemical Pharmacology. 2006, JAN 12; 71(3): 239-247.
  1. 21.   Dishevelled mediates ephrinB1 signalling in the eye field through the planar cell polarity pathway
  2. Lee, H. S.; Bong, Y. S.; Moore, K. B.; Soria, K.; Moody, S. A.; Daar, I. O.
  3. Nature Cell Biology. 2006, JAN; 8(1): 55-63.
  1. 22.   Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells
  2. Du, Y.; Jenkins, N. A.; Copeland, N. G.
  3. Blood. 2005, DEC 1; 106(12): 3932-3939.
  1. 23.   A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer
  2. Burger, A. M.; Gao, Y. G.; Amemiya, Y.; Kahn, H. J.; Kitching, R.; Yang, Y. L.; Sun, P.; Narod, S. A.; Hanna, W. M.; Seth, A. K.
  3. Cancer Research. 2005, NOV 15; 65(22): 10401-10412.
  1. 24.   Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer
  2. Kanao, H.; Enomoto, T.; Kimura, T.; Fujita, M.; Nakashima, R.; Ueda, Y.; Ueno, Y.; Miyatake, T.; Yoshizaki, T.; Buzard, G. S.; Tanigami, A.; Yoshino, K.; Murata, Y.
  3. Cancer Research. 2005, OCT 1; 65(19): 8640-8645.
  1. 25.   C/EBP beta cooperates with RB : E2F to implement Ras(V12)-induced cellular senescence
  2. Sebastian, T.; Malik, R.; Thomas, S.; Sage, J.; Johnson, P. F.
  3. Embo Journal. 2005, SEP 21; 24(18): 3301-3312.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel